JAC Advance Access originally published online on May 24, 2005
Journal of Antimicrobial Chemotherapy 2005 56(1):20-51; doi:10.1093/jac/dki171
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Review |
Efflux-mediated antimicrobial resistance
Department of Microbiology & Immunology, Queen's University, Kingston, ON, Canada K7L 3N6
* Tel: +1-613-533-6677; Fax: +1-613-533-6796; E-mail: poolek{at}post.queensu.ca
Antibiotic resistance continues to plague antimicrobial chemotherapy of infectious disease. And while true biocide resistance is as yet unrealized, in vitro and in vivo episodes of reduced biocide susceptibility are common and the history of antibiotic resistance should not be ignored in the development and use of biocidal agents. Efflux mechanisms of resistance, both drug specific and multidrug, are important determinants of intrinsic and/or acquired resistance to these antimicrobials, with some accommodating both antibiotics and biocides. This latter raises the spectre (as yet generally unrealized) of biocide selection of multiple antibiotic-resistant organisms. Multidrug efflux mechanisms are broadly conserved in bacteria, are almost invariably chromosome-encoded and their expression in many instances results from mutations in regulatory genes. In contrast, drug-specific efflux mechanisms are generally encoded by plasmids and/or other mobile genetic elements (transposons, integrons) that carry additional resistance genes, and so their ready acquisition is compounded by their association with multidrug resistance. While there is some support for the latter efflux systems arising from efflux determinants of self-protection in antibiotic-producing Streptomyces spp. and, thus, intended as drug exporters, increasingly, chromosomal multidrug efflux determinants, at least in Gram-negative bacteria, appear not to be intended as drug exporters but as exporters with, perhaps, a variety of other roles in bacterial cells. Still, given the clinical significance of multidrug (and drug-specific) exporters, efflux must be considered in formulating strategies/approaches to treating drug-resistant infections, both in the development of new agents, for example, less impacted by efflux and in targeting efflux directly with efflux inhibitors.
Keywords: efflux , resistance , antimicrobials , antibiotics , biocides , multidrug
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. P. Tegos, K. Masago, F. Aziz, A. Higginbotham, F. R. Stermitz, and M. R. Hamblin Inhibitors of Bacterial Multidrug Efflux Pumps Potentiate Antimicrobial Photoinactivation Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3202 - 3209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lascols, I. Podglajen, C. Verdet, V. Gautier, L. Gutmann, C.-J. Soussy, E. Collatz, and E. Cambau A Plasmid-Borne Shewanella algae Gene, qnrA3, and Its Possible Transfer In Vivo between Kluyvera ascorbata and Klebsiella pneumoniae J. Bacteriol., August 1, 2008; 190(15): 5217 - 5223. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Moore, R. G. Ledder, P. Gilbert, and A. J. McBain In Vitro Study of the Effect of Cationic Biocides on Bacterial Population Dynamics and Susceptibility Appl. Envir. Microbiol., August 1, 2008; 74(15): 4825 - 4834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Jeannot, S. Elsen, T. Kohler, I. Attree, C. van Delden, and P. Plesiat Resistance and Virulence of Pseudomonas aeruginosa Clinical Strains Overproducing the MexCD-OprJ Efflux Pump Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2455 - 2462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang and T.-F. Mah Involvement of a Novel Efflux System in Biofilm-Specific Resistance to Antibiotics J. Bacteriol., July 1, 2008; 190(13): 4447 - 4452. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Davidson, E. Dassa, C. Orelle, and J. Chen Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems Microbiol. Mol. Biol. Rev., June 1, 2008; 72(2): 317 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cesaro, R. R. D. Bettoni, C. Lascols, A. Merens, C. J. Soussy, and E. Cambau Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes J. Antimicrob. Chemother., May 1, 2008; 61(5): 1007 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hernould, S. Gagne, M. Fournier, C. Quentin, and C. Arpin Role of the AheABC Efflux Pump in Aeromonas hydrophila Intrinsic Multidrug Resistance Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1559 - 1563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L Berg, C. W Crank, A. H Philbrick, and M. K Hayden Efficacy of Ertapenem for Consolidation Therapy of Extended-Spectrum {beta}-lactamase-Producing Gram-Negative Infections: A Case Series Report Ann. Pharmacother., February 1, 2008; 42(2): 207 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Perez, A. M. Hujer, K. M. Hujer, B. K. Decker, P. N. Rather, and R. A. Bonomo Global Challenge of Multidrug-Resistant Acinetobacter baumannii Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3471 - 3484. [Full Text] [PDF]
|
|
|
|
|
|
J. Lubelski, W. N. Konings, and A. J. M. Driessen Distribution and Physiology of ABC-Type Transporters Contributing to Multidrug Resistance in Bacteria Microbiol. Mol. Biol. Rev., September 1, 2007; 71(3): 463 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Daigle, L. Cao, S. Fraud, M. S. Wilke, A. Pacey, R. Klinoski, N. C. Strynadka, C. R. Dean, and K. Poole Protein Modulator of Multidrug Efflux Gene Expression in Pseudomonas aeruginosa J. Bacteriol., August 1, 2007; 189(15): 5441 - 5451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Bohnert, S. Schuster, E. Fahnrich, R. Trittler, and W. V. Kern Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF) J. Antimicrob. Chemother., June 1, 2007; 59(6): 1216 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stavri, L. J. V. Piddock, and S. Gibbons Bacterial efflux pump inhibitors from natural sources J. Antimicrob. Chemother., June 1, 2007; 59(6): 1247 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mahamoud, J. Chevalier, S. Alibert-Franco, W. V. Kern, and J.-M. Pages Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy J. Antimicrob. Chemother., June 1, 2007; 59(6): 1223 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bore, M. Hebraud, I. Chafsey, C. Chambon, C. Skjaeret, B. Moen, T. Moretro, O. Langsrud, K. Rudi, and S. Langsrud Adapted tolerance to benzalkonium chloride in Escherichia coli K-12 studied by transcriptome and proteome analyses Microbiology, April 1, 2007; 153(4): 935 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. V. Hawkyard and R. J. Koerner The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks J. Antimicrob. Chemother., March 1, 2007; 59(3): 347 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Marr, J. Overhage, M. Bains, and R. E. W. Hancock The Lon protease of Pseudomonas aeruginosa is induced by aminoglycosides and is involved in biofilm formation and motility Microbiology, February 1, 2007; 153(2): 474 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kadlec, C. Kehrenberg, and S. Schwarz Efflux-mediated resistance to florfenicol and/or chloramphenicol in Bordetella bronchiseptica: identification of a novel chloramphenicol exporter J. Antimicrob. Chemother., February 1, 2007; 59(2): 191 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Groh, Q. Luo, J. D. Ballard, and L. R. Krumholz Genes That Enhance the Ecological Fitness of Shewanella oneidensis MR-1 in Sediments Reveal the Value of Antibiotic Resistance Appl. Envir. Microbiol., January 1, 2007; 73(2): 492 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lin and A. Martinez Effect of efflux pump inhibitors on bile resistance and in vivo colonization of Campylobacter jejuni J. Antimicrob. Chemother., November 1, 2006; 58(5): 966 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sigal, S. Molshanski-Mor, and E. Bibi No Single Irreplaceable Acidic Residues in the Escherichia coli Secondary Multidrug Transporter MdfA. J. Bacteriol., August 1, 2006; 188(15): 5635 - 5639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Polleichtner and C. Andersen The channel-tunnel HI1462 of Haemophilus influenzae reveals differences to Escherichia coli TolC Microbiology, June 1, 2006; 152(6): 1639 - 1647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. V. Piddock Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria Clin. Microbiol. Rev., April 1, 2006; 19(2): 382 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Morita, M. L. Sobel, and K. Poole Antibiotic Inducibility of the MexXY Multidrug Efflux System of Pseudomonas aeruginosa: Involvement of the Antibiotic-Inducible PA5471 Gene Product. J. Bacteriol., March 1, 2006; 188(5): 1847 - 1855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. V. Kern, P. Steinke, A. Schumacher, S. Schuster, H. v. Baum, and J. A. Bohnert Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli J. Antimicrob. Chemother., February 1, 2006; 57(2): 339 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schumacher, P. Steinke, J. A. Bohnert, M. Akova, D. Jonas, and W. V. Kern Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli J. Antimicrob. Chemother., February 1, 2006; 57(2): 344 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. P. Tegos and M. R. Hamblin Phenothiazinium Antimicrobial Photosensitizers Are Substrates of Bacterial Multidrug Resistance Pumps Antimicrob. Agents Chemother., January 1, 2006; 50(1): 196 - 203. [Abstract] [Full Text] [PDF]
|
|